About Terns Pharmaceuticals, Inc. 
Terns Pharmaceuticals, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 40 Schemes (21.04%)
Foreign Institutions
Held by 75 Foreign Institutions (12.47%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-24 Million
Pharmaceuticals & Biotechnology
USD 3,898 Million ()
NA (Loss Making)
NA
0.00%
-1.04
-33.24%
13.72






